Purpose of Review <p>Food protein–induced allergic proctocolitis (FPIAP) is a frequent cause of rectal bleeding in otherwise healthy infants. Although benign and self-limited, wide variation in diagnostic and management practices often leads to overdiagnosis, unnecessary dietary restriction, and disruption of breastfeeding. This review summarizes contemporary evidence to guide a pragmatic, challenge-anchored approach to diagnosis and management.</p> Recent Findings <p>Diagnosis of FPIAP remains clinical, based on symptom resolution after elimination and recurrence upon reintroduction of the trigger food; however, confirmatory challenges are seldom performed. Fecal calprotectin and other proposed biomarkers—such as eosinophil-derived neurotoxin, zonulin, and microbiome signatures—show poor reliability in infants and are not ready for clinical use. Management should prioritize the least restrictive diet – maternal dairy elimination for breastfed infants and extensively hydrolyzed formulas for formula-fed infants – only in challenge-proven FPIAP. Growing data support earlier reintroduction once colitis resolves, and early introduction of other allergens may reduce future IgE-mediated allergy risk.</p> Summary <p>A standardized, challenge-confirmed framework minimizes over-restriction and supports continued breastfeeding. Future priorities include validation of non-invasive biomarkers and trials comparing timing and strategies for safe dietary reintroduction in FPIAP.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Diagnosis and Management of Food Protein–Induced Allergic Proctocolitis

  • Mahala Leney,
  • Francesca Kahale,
  • Victoria M. Martin

摘要

Purpose of Review

Food protein–induced allergic proctocolitis (FPIAP) is a frequent cause of rectal bleeding in otherwise healthy infants. Although benign and self-limited, wide variation in diagnostic and management practices often leads to overdiagnosis, unnecessary dietary restriction, and disruption of breastfeeding. This review summarizes contemporary evidence to guide a pragmatic, challenge-anchored approach to diagnosis and management.

Recent Findings

Diagnosis of FPIAP remains clinical, based on symptom resolution after elimination and recurrence upon reintroduction of the trigger food; however, confirmatory challenges are seldom performed. Fecal calprotectin and other proposed biomarkers—such as eosinophil-derived neurotoxin, zonulin, and microbiome signatures—show poor reliability in infants and are not ready for clinical use. Management should prioritize the least restrictive diet – maternal dairy elimination for breastfed infants and extensively hydrolyzed formulas for formula-fed infants – only in challenge-proven FPIAP. Growing data support earlier reintroduction once colitis resolves, and early introduction of other allergens may reduce future IgE-mediated allergy risk.

Summary

A standardized, challenge-confirmed framework minimizes over-restriction and supports continued breastfeeding. Future priorities include validation of non-invasive biomarkers and trials comparing timing and strategies for safe dietary reintroduction in FPIAP.